Áttétes emlőrák trials, also abroad
609 open Áttétes emlőrák trials worldwide. Travel and costs are your own unless the study pays them; ask the study team first.
| Ország | Open trials |
|---|---|
| Kína | 224 |
| Egyesült Államok | 222 |
| Franciaország | 82 |
| Spanyolország | 73 |
| Olaszország | 70 |
| All other countries |
The same trial often runs in several countries
A Study of Sacituzumab Tirumotecan (MK-2870) as a Single Agent and in Combination With Pembrolizumab (MK-3475) Versus Treatment of Physician's Choice in Participants With HR+/HER2- Unresectable Locally Advanced or Metastatic Breast Cancer (MK-2870-010) has 6 sites in Chile and runs in 40 countries. If a site near you is full, another one may still take people.
See A Study of Sacituzumab Tirumotecan (MK-2870) as a Single Agent and in Combination With Pembrolizumab (MK-3475) Versus Treatment of Physician's Choice in Participants With HR+/HER2- Unresectable Locally Advanced or Metastatic Breast Cancer (MK-2870-010) in all 40 countries